Deferoxamine in the management of COVID-19 adult patients admitted to ICU: a prospective observational cohort study.

Ann Med Surg (Lond) · 2023 · PMC10205239 · PMID 37229096

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

There was a significantly lower mortality rate in the deferoxamine group in our study, and despite being barely significant, and in view of an obvious underpower, this result may not be conclusive.

also in 134 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.